WHO list of essential IVDs

By Anita Sands | 15 May, 2018

Today, WHO launched the WHO list of essential in vitro diagnostics.

It would not have been possible without the Scientific and Technical Advisory Group on IVDs, and a dedicated WHO secretariat.

Any questions can be directly towards

Attached resource:



Anita Sands Replied at 10:44 AM, 15 May 2018

Here is a link to the actual list, itself....

Attached resource:

Jean Paul Mukundiyukuri Replied at 2:56 PM, 15 May 2018

Thanks Anita for this very important document!

Madhukar Pai Moderator Replied at 7:22 PM, 15 May 2018

This is a big development in global health diagnostics! Congrats to WHO on this first list, which has more than 100 tests!

I hope everyone in this community will help spread the word about this first EDL. We now need countries to adopt and adapt this WHO EDL, and develop National EDLs, and strengthen lab capacity to implement the tests included. Only then will we see impact.

So, please share the WHO EDL with your health ministry officials and encourage them to work on a national list!


Anurag Bhargava Replied at 9:46 PM, 15 May 2018

Dear all,

This is a very good development that places diagnostics as an essential requirement for delivery of rational health care.

I am particularly pleased that the Indian Council of Medical Research(ICMR) and McGill University organised a national consultation toward evolving an EDL for India in February 2018. This was a very productive meeting with presentations ( including by me) and panel discussions. The clear consensus that emerged was for a comprehensive and graded list. At that time, the WHO was thinking of discussing IVDs related only to 4 diseases. I think the SAGE-IVD which included Madhu Pai (Canada) and Kamini Walia (india) contributed to this shift in thinking.

This has now to be followed by development of National EDLs and more importantly ensuring access to essential diagnostics

Anurag Bhargava

Dr. Khin Yi Oo Replied at 4:29 AM, 16 May 2018

Dear Anita,
Thank you for your information. This is very useful for us. I will share
them with the National counterparts. I retired as Deputy Director
responsible for Public Health Microbiology at the National Health
Laboratory, Yangon. And just after retirement, I joined Clinton Health
Access Initiative CHAI, Myanmar as Program Manager for Hepatitis and then
the next year I worked as Laboratory Advisor at CHAI, Myanmar. I'm working
closely with the National Hepatitis Control Program and CHAI is supporting
them in their treatment of HCV infection, including drugs, training and
laboratory support. We met at the Melbourne Infectious Disease Seminar a
few years back. I enjoyed my discussion with you regarding our Algorithm
for HIV testing.